Genmab's total assets for Q1 2026 were kr12.38B, a decrease of -3.64% from the previous quarter. GMAB total liabilities were kr6.69B for the fiscal quarter, a -4.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.